What is the management for a pregnant patient with hypertension (high blood pressure), headache, and seizure?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 4, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Eclampsia in Pregnancy

This patient has eclampsia (seizure in the setting of severe preeclampsia) and requires immediate administration of magnesium sulfate for seizure control, urgent IV antihypertensive therapy to reduce blood pressure to safe levels (systolic 110-140 mmHg, diastolic 85 mmHg), and expedited delivery after maternal stabilization. 1

Immediate Seizure Management

Administer magnesium sulfate immediately - this is the definitive treatment for eclamptic seizures and prevention of recurrent seizures. 2, 1, 3

  • Loading dose: 4-5g IV over 5 minutes 1
  • Maintenance dose: 1-2g/hour continuous IV infusion 1
  • Magnesium sulfate is superior to other anticonvulsants (including phenytoin and diazepam) for both treatment and prevention of eclamptic seizures 4, 3

During active seizure:

  • Position patient on left side to prevent aspiration 5
  • Ensure airway patency and administer oxygen 5
  • Do not attempt to restrain or place objects in mouth 4

Urgent Blood Pressure Control

Initiate IV antihypertensive therapy immediately when BP ≥160/110 mmHg persists for more than 15 minutes. 2, 1

First-line IV antihypertensive options: 2, 1

  • IV Labetalol: 20mg IV bolus, then 40mg after 10 minutes, followed by 80mg every 10 minutes to maximum 220mg 1
  • IV Hydralazine: Alternative option, though associated with more perinatal adverse effects than labetalol 2
  • Oral nifedipine: 10mg orally can be used for non-severe hypertension 2, 5

Target blood pressure: Systolic 110-140 mmHg and diastolic 85 mmHg (or at minimum <160/105 mmHg) 2, 1

Critical warning: Avoid short-acting oral nifedipine when combined with magnesium sulfate due to risk of uncontrolled hypotension and fetal compromise. 1, 6 Careful blood pressure monitoring is essential when using this combination. 6

Diagnostic Workup

Immediate laboratory assessment: 2, 1

  • Complete blood count (hemoglobin, platelet count) - assess for HELLP syndrome
  • Comprehensive metabolic panel (creatinine, liver enzymes including ALT and LDH)
  • Coagulation studies (fibrinogen, D-dimer, PT)
  • Urine protein-to-creatinine ratio or 24-hour urine collection
  • Serum uric acid

Look for signs of HELLP syndrome: 2, 7

  • Hemolysis (elevated LDH, decreased haptoglobin)
  • Elevated liver enzymes (ALT, AST)
  • Low platelet count (<100 × 10⁹/L)
  • Right upper quadrant or epigastric pain

Critical Monitoring Requirements

Continuous maternal monitoring: 1

  • Blood pressure every 15 minutes until stable, then hourly
  • Deep tendon reflexes before each magnesium dose (to detect toxicity)
  • Respiratory rate (magnesium toxicity causes respiratory depression)
  • Hourly urine output via Foley catheter (target ≥100 mL/4 hours or >35 mL/hour)
  • Oxygen saturation (maintain >95%)
  • Level of consciousness (assess for confusion, agitation, unresponsiveness)

Fetal monitoring: 1

  • Continuous fetal heart rate monitoring
  • Ultrasound assessment of fetal status, biometry, and amniotic fluid

Delivery Planning

Delivery is the definitive cure and should be expedited after maternal stabilization. 2, 1, 8

Absolute indications for immediate delivery (after stabilization): 1

  • Eclampsia (this patient)
  • Inability to control BP despite ≥3 classes of antihypertensives
  • Progressive thrombocytopenia or worsening liver/renal function
  • Pulmonary edema
  • Non-reassuring fetal status
  • Gestational age ≥34 weeks

Before delivery at <35 weeks: 2

  • Administer corticosteroids (betamethasone or dexamethasone) for fetal lung maturity per national guidance
  • Magnesium sulfate also provides neuroprotection if delivery required before 32 weeks

Mode of delivery: 1

  • Vaginal delivery is preferred unless cesarean indicated for obstetric reasons
  • Induction of labor is associated with improved maternal outcomes

Special Considerations and Pitfalls

Magnesium sulfate toxicity monitoring: 1

  • Loss of deep tendon reflexes is the first sign of toxicity
  • Respiratory depression occurs at higher levels
  • Have calcium gluconate 1g IV available as antidote

Avoid these medications: 1

  • Sodium nitroprusside (except extreme emergencies - risk of fetal cyanide poisoning)
  • ACE inhibitors, ARBs, direct renin inhibitors (absolutely contraindicated - severe fetotoxicity)
  • Diuretics (worsen plasma volume depletion)

For pulmonary edema: 1

  • IV nitroglycerin is drug of choice (starting 5 mcg/min, titrate to maximum 100 mcg/min)
  • Do not use routine plasma volume expansion

Postpartum care: 2, 7

  • Continue magnesium sulfate for 24-48 hours postpartum
  • Eclampsia can occur up to 1 month postpartum (late postpartum eclampsia) 3
  • Monitor blood pressure closely - most resolve within 42 days but some require continued antihypertensive therapy

Transfer considerations: 1

  • If not at a facility with maternal-fetal medicine expertise and level 2/3 care capability, initiate magnesium sulfate and blood pressure control prior to medicalized transport
  • Coordinate with receiving obstetric and anesthesia teams before transfer

References

Guideline

Management of Severe Preeclampsia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Advances in the understanding of eclampsia.

Current hypertension reports, 2008

Research

Emergency management of eclampsia and severe pre-eclampsia.

Emergency medicine (Fremantle, W.A.), 2003

Research

HELLP Syndrome.

Critical care nursing clinics of North America, 2022

Research

Diagnosis and management of pre-eclampsia: an update.

International journal of women's health, 2010

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.